Administrative Core
行政核心
基本信息
- 批准号:10038021
- 负责人:
- 金额:$ 30.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-01 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:AgingAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAmerican IndiansAreaBasic ScienceBiological MarkersBloodBlood VesselsBudgetsCaringChairpersonClinicalCognitiveCollaborationsCommunicationCommunitiesCommunity HealthConsentDataData SetDatabasesDementiaDiagnosisElderlyEnsureEventFacultyFundingFunding MechanismsGeriatricsGoalsGovernment OfficialsGrantGuidelinesHeadHealth OccupationsHumanImageImage AnalysisImaging DeviceIncidenceInflammationInformation SystemsInfrastructureLinkMagnetic Resonance ImagingMemoryMentorshipMethodsMind-Body MethodMolecularNeurologyNeuropsychologyNeurosciencesNew MexicoNewsletterPatient RecruitmentsPhysiciansPilot ProjectsPopulationPrevalenceProceduresProcessPueblo RaceResearchResearch PersonnelResearch Project GrantsResourcesRoleRural MinorityScienceScientistSenior ScientistServicesSiteState GovernmentStudentsTestingTextbooksTimeTissue SampleTrainingTranslational ResearchTrustUnderrepresented MinorityUnited States National Institutes of HealthUniversitiesVascular DiseasesWorkadvocacy organizationsclinical practicecommunity organizationsdata submissionearly-career facultyexperiencehealth care serviceinnovationinsightinterestmedical schoolsmeetingsmemberneuroimagingnext generationoutreachprogramsquality assuranceranpirnaserural Americansscreeningservice providerssocial mediatau Proteinstraining opportunitytransmission processundergraduate studenturban Native Americanvaccine developmentvascular factorweb site
项目摘要
Abstract Administrative Core:
The Administrative Core (AC) of New Mexico Exploratory Alzheimer’s Disease Research Center (NM
eADRC) is critical for the management of the center by convening committees and interacting with
NACC, NCRAD, and NIA. NM eADRC creates an infrastructure for AD science in New Mexico, raising
the level of research participation in rural American Indian (AI) communities, and increasing the
understanding of the role of vascular disease in AD and related dementias (AD/ADRD) through the use
of biomarkers and advances in neuroimaging. The AC will ensure the successful completion of the aims
in the Overall, Clinical and Scientific Cores. The AC will form committees to help achieve the goals of the
NM eADRC. The AC will link senior scientists with junior faculty, trainees, clinical practice physicians and
community health representatives (CHRs). The scientists in the NM eADRC are accomplished
investigators with extensive experience managing large research projects, training junior investigators,
and working as a team. The PI was head of Neurology at UNM and is director of the Center for Memory
and Aging. As Chair, he managed two neuroscience CoBRE grants. The Co-Director of the NM eADRC
is a nationally recognized researcher in AD and a leader in the development of a vaccine against tau
protein. The AC Co-Leader is trained in geriatrics and neurology, co-edited the textbook on geriatric
neurology and has engaged with local communities and state-wide organizations for many years in
dementia related activities. Neuropsychology will be directed by Drs. Sadek and Prestopnik and
neuroimaging by Drs. Caprihan and Kiehl. A demonstration/pilot project will use community health
representatives and mobile MR imaging to bring AD research to the tribal areas with the Mobile On-Site
Screening and Testing (MOSST), using the two mobile 1.5T MRI scanners at the MIND Research
Network. The innovative work on developing vascular biomarkers will add a vascular component to the
NIA-AA criterial for AD. BBB studies developed at UNM will provide insight into mechanisms of
inflammation. A major advantage of the NM eADRC is the ability to include data from underrepresented
minorities in the NACC, ADNI, and NCRAD databases. The NM eADRC will bring to the southwest a
major center for research and innovative care in AD/ADRD that will utilize the outstanding scientific
resources in the state, while building a greater understanding of the needs of rural and minority
populations.
行政核心:
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gary Allen Rosenberg其他文献
Gary Allen Rosenberg的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gary Allen Rosenberg', 18)}}的其他基金
Validation of Biomarkers of Small Vessel Injury in VCID
VCID 中小血管损伤生物标志物的验证
- 批准号:
10611827 - 财政年份:2021
- 资助金额:
$ 30.78万 - 项目类别:
New Mexico Alzheimer's Disease Research Center
新墨西哥州阿尔茨海默病研究中心
- 批准号:
10038020 - 财政年份:2020
- 资助金额:
$ 30.78万 - 项目类别:
New Mexico Alzheimer's Disease Research Center
新墨西哥州阿尔茨海默病研究中心
- 批准号:
10227133 - 财政年份:2020
- 资助金额:
$ 30.78万 - 项目类别:
New Mexico Alzheimer's Disease Research Center
新墨西哥州阿尔茨海默病研究中心
- 批准号:
10450033 - 财政年份:2020
- 资助金额:
$ 30.78万 - 项目类别:
Validation of Biomarkers of Small Vessel Injury in VCID
VCID 中小血管损伤生物标志物的验证
- 批准号:
10369502 - 财政年份:2016
- 资助金额:
$ 30.78万 - 项目类别:
MRI and CSF Biomarkers of White Matter Injury in VCID
VCID 患者脑白质损伤的 MRI 和 CSF 生物标志物
- 批准号:
9356351 - 财政年份:2016
- 资助金额:
$ 30.78万 - 项目类别:
MRI and CSF Biomarkers of White Matter Injury in VCID
VCID 患者脑白质损伤的 MRI 和 CSF 生物标志物
- 批准号:
9768242 - 财政年份:2016
- 资助金额:
$ 30.78万 - 项目类别:
Matrix Metalloproteinase Inhibitors in Stroke
基质金属蛋白酶抑制剂在中风中的应用
- 批准号:
7845519 - 财政年份:2009
- 资助金额:
$ 30.78万 - 项目类别:














{{item.name}}会员




